Chemoinformaics analysis of CITRONELLYL VALERATE
| Molecular Weight | 240.387 | nRot | 9 |
| Heavy Atom Molecular Weight | 212.163 | nRig | 2 |
| Exact Molecular Weight | 240.209 | nRing | 0 |
| Solubility: LogS | -5.378 | nHRing | 0 |
| Solubility: LogP | 5.395 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 45.3242 |
| nHD | 0 | BPOL | 30.6938 |
| QED | 0.438 |
| Synth | 2.755 |
| Natural Product Likeliness | 1.363 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.702 |
| Pgp-sub | 0.002 |
| HIA | 0.003 |
| CACO-2 | -4.444 |
| MDCK | 0.0000224 |
| BBB | 0.345 |
| PPB | 0.976067 |
| VDSS | 1.973 |
| FU | 0.026565 |
| CYP1A2-inh | 0.974 |
| CYP1A2-sub | 0.214 |
| CYP2c19-inh | 0.683 |
| CYP2c19-sub | 0.438 |
| CYP2c9-inh | 0.789 |
| CYP2c9-sub | 0.867 |
| CYP2d6-inh | 0.048 |
| CYP2d6-sub | 0.08 |
| CYP3a4-inh | 0.299 |
| CYP3a4-sub | 0.167 |
| CL | 14.289 |
| T12 | 0.318 |
| hERG | 0.022 |
| Ames | 0.003 |
| ROA | 0.017 |
| SkinSen | 0.945 |
| Carcinogencity | 0.176 |
| EI | 0.953 |
| Respiratory | 0.325 |
| NR-Aromatase | 0.013 |
| Antiviral | Yes |
| Prediction | 0.798887 |